Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The TEA domain transcription factors (TEADs) are a family of transcription factors that regulate gene expression related to cell proliferation, development, and tumorigenesis. They bind DNA via the TEA domain and interact with cofactors like YAP/TAZ to activate transcription. Dysregulation of TEADs is implicated in various diseases, including cancer and vascular disease, making them therapeutic targets. Current strategies focus on disrupting YAP/TAZ-TEAD interaction with small-molecule inhibitors.
Inhibition of YAP/TAZ-TEAD interaction via targeting the palmitate-binding pocket in the TEAD C-terminal region.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on TEA Domain Transcription Factor (TEAD Family) (TEAD).